Nemaura Medical Inc buy EF Hutton Acquisition Co. I
Start price
28.02.23
/
50%
€0.51
Target price
28.02.24
€5.64
Performance (%)
-
End price
29.02.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nemaura Medical Inc | - | - | - |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% |
Comments by EF_Hutton_Acquisitio for this prediction
In the thread Nemaura Medical Inc diskutieren
Nemaura Medical Inc. (NASDAQ: NMRD) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $6.00 price target on the stock.
Ratings data for NMRD provided by MarketBeat
In the thread Trading Nemaura Medical Inc
Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten